ClinicalTrials.gg
Drug

Hyaluronoglucosaminidase clinical trials

Also written Hyaluronidase, Amphadase® and rHuPH20.

A group of medicines. Hyaluronidase (human recombinant) (69 studies) is counted on its own page; this page counts the studies that name Hyaluronoglucosaminidase itself.

studies test it
32
open now
6
in phase 3
7
first study started
2007

How each study uses Hyaluronoglucosaminidase is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Hyaluronoglucosaminidase studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
5 May 2004 · VITRASE · BLA 021640 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Hylenex
2
hyaluronoglucosaminidase
1

Brand

Amphadase®
2

Development codes

rHuPH20
2

Other names

Hyaluronidase
17

In one entry with another drug

Given together, or one or the other

HYQVIA
7
IGI 10% with rHuPH20
3
Daratumumab / Hyaluronidase Injection
2

Medicines filed under Hyaluronoglucosaminidase

As reviewed, so not every one. Each counts its studies on its own page, not here.

Studies by the year they started

31 studies that test it; most in 2017 (4)

Studies that test Hyaluronoglucosaminidase, by start year
YearStudies
20072
20122
20131
20141
20151
20162
20174
20181
20201
20212
20223
20232
20243
20253
20263

Who runs them

Industry 9 · Other 23

Baxalta now part of Shire (5) · Assiut University (3) · Benha University (2) · Stanford University (2) · Cairo University (2) · Johns Hopkins University (1) · Misr University for Science and Technology (1) · Northwestern University (1)

Often tested with

Tested in the same studies.

Immunoglobulin G (7) · Lidocaine (2) · Immunoglobulins, Intravenous (2) · Daratumumab (2) · Dexmedetomidine (1) · Immunoglobulins (1) · Ceftriaxone (1) · Sodium Bicarbonate (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 3

Studies that test Hyaluronoglucosaminidase.

Studies

Open first, then newest update. How each study uses Hyaluronoglucosaminidase is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 32

See all 32 studies that test Hyaluronoglucosaminidase →

Given beside what is tested · 5 — Hyaluronoglucosaminidase is usual care or a partner of the new treatment
As the comparator · 2 — what is tested is compared with Hyaluronoglucosaminidase

What changed recently

From the registry's own updates since Oct 18, 2026.

Codes

What other systems call Hyaluronoglucosaminidase · ClinicalTrials.gg INT007623

  • RxNorm 5464One source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.